Alkermes plc
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.48B | $1.56B | $1.66B | $1.11B | $1.17B | $1.04B | $1.17B | $1.09B |
| VIVITROL | $467.9M | $457.3M | $400.4M | $379.5M | $343.9M | $310.7M | $335.4M | $302.6M |
| ARISTADA and ARISTADA INITIO | $370.0M | $346.2M | $327.7M | $302.1M | $275.4M | $241.0M | $189.1M | $147.7M |
| LYBALVI | $346.7M | $280.0M | $191.9M | $96.0M | $8.2M | $0 | $0 | $0 |
| Product sales net (unspecified product) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Manufacturing and royalty revenues | $291.3M | $474.1M | $743.4M | $332.0M | $541.8M | $484.0M | $447.9M | $526.7M |
| Manufacturing revenues | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Royalty revenues | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| License revenue | $0 | $0 | $0 | $2.0M | $3.5M | $1.1M | $145.8M | $48.4M |
| Research and development revenue | $0 | $3.0K | $19.0K | $260.0K | $1.0M | $1.9M | $52.8M | $68.9M |
| Net collaborative profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $196.5M | $245.3M | $253.0M | $218.1M | $197.3M | $178.3M | $180.4M | $176.4M |
| Gross Profit | $1.28B | $1.31B | $1.41B | $893.7M | $976.4M | $860.4M | $990.6M | $917.9M |
| Gross Margin | 86.7% | 84.2% | 84.8% | 80.4% | 83.2% | 82.8% | 84.6% | 83.9% |
| Operating Expenses | ||||||||
| Research & Development | $324.0M | $245.3M | $270.8M | $272.7M | $290.9M | $394.6M | $512.8M | $425.4M |
| SG&A Expense | $701.5M | $645.2M | $689.8M | $590.8M | $549.6M | $538.8M | $599.4M | $526.4M |
| Operating Income | $254.0M | $420.6M | $414.1M | $-6.1M | $97.7M | $-112.4M | $-175.5M | $-99.1M |
| Operating Margin | 17.2% | 27.0% | 24.9% | -0.5% | 8.3% | -10.8% | -15.0% | -9.1% |
| Interest Expense | — | — | $23.0M | $13.0M | $11.2M | $8.7M | $13.6M | $15.4M |
| Pretax Income | $291.5M | $443.8M | $421.5M | $-31.1M | $87.7M | $-96.5M | $-197.1M | $-127.0M |
| Income Tax Expense | $49.8M | $71.6M | $-97.6M | $2.0M | $11.3M | $14.3M | $-436.0K | $12.3M |
| Net Income | $241.7M | $367.1M | $355.8M | $-158.3M | $-48.2M | $-110.9M | $-196.6M | $-139.3M |
| Net Margin | 16.4% | 23.6% | 21.4% | -14.2% | -4.1% | -10.7% | -16.8% | -12.7% |
| EPS (Basic) | $1.47 | $2.22 | $2.14 | $-0.97 | $-0.30 | $-0.70 | $-1.25 | $-0.90 |
| EPS (Diluted) | $1.43 | $2.17 | $2.10 | $-0.97 | $-0.29 | $-0.70 | $-1.25 | $-0.90 |
| Shares Outstanding (Basic) | 164.7M | 165.4M | 166.2M | 163.7M | 160.9M | 158.8M | 157.8M | 155.8M |
| Shares Outstanding (Diluted) | 168.7M | 169.2M | 169.7M | 163.7M | 164.8M | 158.8M | 157.8M | 155.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |